CNTB Connect Biopharma Holdings Limited - Ordinary Shares
$2,27
Precio · May 20, 2026
Fundamentales a fecha de May 12, 2026
Rango 52S
$1–$4
50% of range
Calificación del Analista
BUY
11 analysts
Precio Objetivo
$8
+248% upside
P/E (TTM)
-2.8
ROE
-97.9%
Margen de Beneficio Neto
-86687.5%
CNTB Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$2.27
Capitalización Bursátil
$159M
P/E (TTM)
-2.8
BPA (TTM)
$-1.00
Ingresos (TTM)
$64.0K
Rendimiento div.
—
ROE
-97.9%
Deuda/Capital
—
Rango 52S
$1 – $4
CNTB Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$64.0K
2023-12-31
→
2025-12-31
BPA
$-1.00
2023-12-31
→
2025-12-31
Flujo de caja libre
$-52M
2024-12-31
→
2025-12-31
Márgenes
-86687.5%
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
CNTB
Mediana de Pares
P/E (TTM)
-2.8
579.2
P/S (TTM) (P/V (TTM))
2487.0
14.1
P/B (P/C)
3.8
2.2
Price / FCF (Precio / FCF)
-3.1
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
CNTB
Mediana de Pares
Operating Margin (Margen Operativo)
-90740.6%
—
Net Profit Margin (Margen de Beneficio Neto)
-86687.5%
-505.5%
ROA
-70.5%
-57.6%
ROE
-97.9%
-77.2%
ROIC
-138.8%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
CNTB
Mediana de Pares
Current Ratio (Ratio corriente)
3.7
3.6
Quick Ratio (Ratio Rápido)
3.3
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
CNTB
Mediana de Pares
Revenue YoY (Ingresos interanuales)
-99.8%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
CNTB
Mediana de Pares
CNTB Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
11 analistas
- Compra fuerte 4 36,4%
- Compra 6 54,5%
- Mantener 1 9,1%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
5 analistas · 2026-05-18
Mediana
$7.50
Media
$7.90
← Por Debajo de Todos los Objetivos
$2.27
Mín
$6.00
Máx
$10.00
Objetivo mediano
$7.50
+230,4%
Objetivo medio
$7.90
+248,0%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
1.1%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de marzo de 2026 | $-0.34 | $-1.22 | 0.88% |
| 31 de diciembre de 2025 | $-1.91 | $-1.44 | -0.47% |
| 30 de septiembre de 2025 | $-0.31 | $-1.01 | 0.70% |
| 30 de junio de 2025 | $-0.23 | $-0.92 | 0.69% |
| 31 de marzo de 2025 | $-0.19 | $-1.92 | 1.7% |
| 30 de junio de 2023 | $-3.90 | $-7.07 | 3.2% |
Comparación con pares Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| CNTB | $159M | -2.8 | -99.8% | -86687.5% | -97.9% | — |
| HRTX | $245M | -10.8 | 7.4% | -13.0% | 312.5% | 73.3% |
| SPRO | $131M | 15.5 | 39.2% | 12.8% | 18.7% | — |
| HURA | — | -1.2 | — | — | — | — |
| IMUX | — | -0.9 | — | — | — | — |
| OKUR | — | -0.7 | — | -1733.7% | -88.6% | — |
| GALT | $271M | -8.7 | — | — | 25.0% | — |
| VTVT | — | — | — | — | -70.4% | — |
| SPRB | $120M | -1.7 | -51.3% | — | -139.9% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 14
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $64.0K | $26M | $0 | |
| R&D Expense | $38M | $29M | $53M | |
| SG&A Expense | $20M | $19M | $16M | |
| Operating Expenses | $58M | $48M | $69M | |
| Operating Income | $-58M | $-22M | $-69M | |
| Other Non-op | $523.0K | $3M | $2M | |
| Pretax Income | $-55M | $-15M | $-62M | |
| Income Tax | $197.0K | $223.0K | $120.0K | |
| Net Income | $-55M | $-16M | $-62M | |
| EPS (Basic) | $-1.00 | $-0.28 | $-1.13 | |
| EPS (Diluted) | $-1.00 | $-0.28 | $-1.13 | |
| Shares (Basic) | 55,660,000 | 55,213,000 | 55,067,000 | |
| Shares (Diluted) | 55,660,000 | 55,213,000 | 55,067,000 | |
| EBITDA | $-57M | $-22M | · |
Balance general 26
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $38M | $78M | $106M | |
| Short-term Investments | $6M | $15M | $13M | |
| Receivables | $13.0K | $789.0K | $0 | |
| Prepaid Expense | $7M | $2M | $4M | |
| Other Current Assets | · | $53.0K | $54.0K | |
| Current Assets | $51M | $97M | $123M | |
| PP&E (Net) | $4M | $4M | $4M | |
| PP&E (Gross) | $7M | $7M | $6M | |
| Accum. Depreciation | $3M | $3M | $2M | |
| Intangibles | $45.0K | $53.0K | $62.0K | |
| Other Non-current Assets | $646.0K | $33.0K | $24.0K | |
| Total Assets | $56M | $101M | $127M | |
| Accounts Payable | $2M | $342.0K | $2M | |
| Accrued Liabilities | $11M | $8M | $9M | |
| Current Liabilities | $14M | $8M | $25M | |
| Capital Leases | $368.0K | $24.0K | $180.0K | |
| Other Non-current Liabilities | $114.0K | $632.0K | · | |
| Total Liabilities | $14M | $9M | $26M | |
| Common Stock | $10.0K | $10.0K | $10.0K | |
| Paid-in Capital | $444M | $439M | $432M | |
| Retained Earnings | $-401M | $-345M | $-330M | |
| Treasury Stock | $180.0K | $180.0K | $180.0K | |
| AOCI | $-1M | $-2M | $-1M | |
| Stockholders' Equity | $42M | $92M | $101M | |
| Liabilities + Equity | $56M | $101M | $127M | |
| Shares Outstanding | 56,442,308 | 55,349,000 | 55,103,000 |
Flujo de Efectivo 11
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $704.0K | $660.0K | $720.0K | |
| Stock-based Comp | $4M | $7M | $5M | |
| Restructuring | · | $3M | · | |
| Other Non-cash | $-156.0K | $-15M | · | |
| Operating Cash Flow | $-51M | $-24M | $-48M | |
| CapEx | $434.0K | $750.0K | $81.0K | |
| Investing Cash Flow | $10M | $-3M | $75M | |
| Financing Cash Flow | $1M | $227.0K | $45.0K | |
| Net Change in Cash | $-40M | $-27M | $27M | |
| Taxes Paid | · | $111.0K | $120.0K | |
| Free Cash Flow | $-52M | $-24M | · |
Rentabilidad 7
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | -90740.6% | -86.2% | · | |
| Net Margin | -86687.5% | -60.0% | · | |
| Pretax Margin | -86379.7% | -59.2% | · | |
| EBITDA Margin | -89640.6% | -83.7% | · | |
| ROA | -70.5% | -13.7% | · | |
| ROE | -97.9% | -16.2% | · | |
| ROIC | -138.8% | -24.7% | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 3.7 | 11.5 | · | |
| Quick Ratio | 3.3 | 11.2 | · |
Eficiencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.2 | · | |
| Receivables Turnover | 0.2 | 66.0 | · |
Tasas de Crecimiento 1
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | -99.8% | · | · |
Valoración (TTM) 10
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $64.0K | $26M | · | |
| Net Income TTM | $-55M | $-16M | · | |
| Market Cap | $159M | $76M | · | |
| P/E | -2.8 | -4.9 | · | |
| P/S | 2487.0 | 2.9 | · | |
| P/B | 3.8 | 0.8 | · | |
| P / Tangible Book | 3.8 | 0.8 | · | |
| P / Cash Flow | -3.1 | -3.2 | · | |
| P / FCF | -3.1 | -3.1 | · | |
| Earnings Yield | -35.5% | -20.3% | · |
Estado de resultados 14
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $169.0K | $0 | $16.0K | $48.0K | $0 | $698.0K | $1M | $24M | |
| R&D Expense | $15M | $11M | $11M | $9M | $7M | $6M | $9M | $5M | |
| SG&A Expense | $5M | $4M | $7M | $5M | $5M | $4M | $6M | $5M | |
| Operating Expenses | $20M | $16M | $18M | $13M | $11M | $10M | $15M | $10M | |
| Operating Income | $-20M | $-16M | $-18M | $-13M | $-11M | $-10M | $-14M | $14M | |
| Other Non-op | $-3.0K | $60.0K | $-7.0K | $-39.0K | $509.0K | $-30.0K | $-108.0K | $9.0K | |
| Pretax Income | $-19M | $-15M | $-17M | $-13M | $-10M | $-9M | $-13M | $15M | |
| Income Tax | $48.0K | $27.0K | $61.0K | $55.0K | $54.0K | $106.0K | $57.0K | $30.0K | |
| Net Income | $-19M | $-15M | $-17M | $-13M | $-10M | $-9M | $-13M | $15M | |
| EPS (Basic) | $-0.34 | $-0.27 | $-0.31 | $-0.23 | $-0.19 | $-0.16 | $-0.23 | $0.27 | |
| EPS (Diluted) | $-0.34 | $-0.27 | $-0.31 | $-0.23 | $-0.19 | $-0.16 | $-0.23 | $0.27 | |
| Shares (Basic) | 56,545,000 | -110,906,000 | 55,716,000 | 55,498,000 | 55,352,000 | -110,330,000 | 55,254,000 | 55,186,000 | |
| Shares (Diluted) | 56,545,000 | -110,906,000 | 55,716,000 | 55,498,000 | 55,352,000 | -110,854,000 | 55,254,000 | 55,710,000 | |
| EBITDA | $-19M | · | $-18M | $-13M | $-11M | · | · | · |
Balance general 26
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $46M | $38M | $38M | $41M | $48M | $78M | · | · | |
| Short-term Investments | $0 | $6M | $17M | $31M | $36M | $15M | · | · | |
| Receivables | $0 | $13.0K | $17.0K | $0 | $8.0K | $789.0K | · | · | |
| Prepaid Expense | $9M | $7M | $8M | $6M | $4M | $2M | · | · | |
| Other Current Assets | · | · | · | $228.0K | $65.0K | · | · | · | |
| Current Assets | $55M | $51M | $63M | $78M | $88M | $97M | · | · | |
| PP&E (Net) | $4M | $4M | $4M | $4M | $4M | $4M | · | · | |
| PP&E (Gross) | · | $7M | · | · | · | $7M | · | · | |
| Accum. Depreciation | · | $3M | · | · | · | $3M | · | · | |
| Intangibles | $43.0K | $45.0K | $47.0K | $48.0K | $50.0K | $53.0K | · | · | |
| Other Non-current Assets | $646.0K | $646.0K | $45.0K | $45.0K | $45.0K | $33.0K | · | · | |
| Total Assets | $60M | $56M | $67M | $83M | $93M | $101M | · | · | |
| Accounts Payable | $4M | $2M | $2M | $2M | $817.0K | $342.0K | · | · | |
| Accrued Liabilities | $12M | $11M | $9M | $8M | $7M | $8M | · | · | |
| Current Liabilities | $17M | $14M | $11M | $11M | $9M | $8M | · | · | |
| Capital Leases | $287.0K | $368.0K | $445.0K | $520.0K | $594.0K | $24.0K | · | · | |
| Other Non-current Liabilities | $111.0K | $114.0K | $118.0K | $122.0K | $627.0K | $632.0K | · | · | |
| Total Liabilities | $17M | $14M | $12M | $11M | $10M | $9M | · | · | |
| Common Stock | $11.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | · | · | |
| Paid-in Capital | $464M | $444M | $443M | $441M | $440M | $439M | · | · | |
| Retained Earnings | $-420M | $-401M | $-386M | $-369M | $-356M | $-345M | · | · | |
| Treasury Stock | $180.0K | $180.0K | $180.0K | $180.0K | $180.0K | $180.0K | · | · | |
| AOCI | $-1M | $-1M | $-1M | $-1M | $-2M | $-2M | · | · | |
| Stockholders' Equity | $43M | $42M | $55M | $71M | $83M | $92M | · | · | |
| Liabilities + Equity | $60M | $56M | $67M | $83M | $93M | $101M | · | · | |
| Shares Outstanding | 62,711,690 | 56,442,308 | 55,786,000 | 55,580,000 | 55,352,000 | 55,349,208 | · | · |
Flujo de Efectivo 13
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $164.0K | $181.0K | $179.0K | $171.0K | $173.0K | $158.0K | $176.0K | $162.0K | |
| Stock-based Comp | $1M | $917.0K | $916.0K | $951.0K | $942.0K | $1M | $2M | $2M | |
| Restructuring | · | · | · | · | · | $0 | $2M | $1M | |
| Other Non-cash | $2M | · | · | · | $-802.0K | · | · | · | |
| Operating Cash Flow | $-16M | $-11M | $-17M | $-13M | $-10M | $-2M | $-13M | $-8M | |
| CapEx | $0 | $16.0K | $34.0K | $303.0K | $81.0K | $313.0K | $147.0K | $290.0K | |
| Investing Cash Flow | $6M | $11M | $14M | $5M | $-21M | $-16M | $-147.0K | $3M | |
| Stock Issued | $137.0K | · | · | · | $2.0K | · | · | · | |
| Net Stock Activity | $137.0K | · | · | · | · | · | · | · | |
| Financing Cash Flow | $18M | $715.0K | $215.0K | $161.0K | $2.0K | $106.0K | $0 | $121.0K | |
| Net Change in Cash | $8M | $500.0K | $-3M | $-7M | $-31M | $-19M | $-13M | $-4M | |
| Taxes Paid | · | · | $0 | · | · | · | $111.0K | · | |
| Free Cash Flow | $-16M | · | · | · | $-10M | · | · | · |
Rentabilidad 7
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -11601.8% | · | -110481.2% | -27966.7% | · | · | · | · | |
| Net Margin | -11478.1% | · | -107500.0% | -26872.9% | · | · | · | · | |
| Pretax Margin | -11449.7% | · | -107118.8% | -26758.3% | · | · | · | · | |
| EBITDA Margin | -11504.7% | · | -110481.2% | -27966.7% | · | · | · | · | |
| ROA | -25.4% | · | -51.1% | -31.2% | -22.2% | · | · | · | |
| ROE | -30.9% | · | -62.1% | -36.2% | -24.8% | · | · | · | |
| ROIC | -46.1% | · | -32.0% | -18.9% | -13.9% | · | · | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | · | 5.5 | 7.2 | 10.2 | · | · | · | |
| Quick Ratio | 2.7 | · | 4.8 | 6.7 | 9.8 | · | · | · |
Eficiencia 2
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | · | · | · | · | |
| Receivables Turnover | 42.2 | · | 1.9 | · | · | · | · | · |
Valoración (TTM) 10
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $233.0K | · | · | · | · | · | · | · | |
| Net Income TTM | $-60M | · | $-53M | $-21M | $-17M | · | · | · | |
| Market Cap | $164M | · | $84M | $54M | $30M | · | · | · | |
| P/E | -2.4 | · | -1.6 | -2.6 | -1.8 | · | · | · | |
| P/S | 705.2 | · | · | · | · | · | · | · | |
| P/B | 3.9 | · | 1.5 | 0.8 | 0.4 | · | · | · | |
| P / Tangible Book | 3.9 | · | 1.5 | 0.8 | 0.4 | · | · | · | |
| P / Cash Flow | -10.3 | · | · | · | -3.1 | · | · | · | |
| P / FCF | -10.3 | · | · | · | -3.0 | · | · | · | |
| Earnings Yield | -40.8% | · | -63.6% | -38.8% | -56.4% | · | · | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Ingresos | $64.0K | $26M | $0 |
| Margen Operativo % | -90740.6% | -86.2% | — |
| Beneficio neto | $-55M | $-16M | $-62M |
| EPS Diluido | $-1.00 | $-0.28 | $-1.13 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Ratio corriente | 3.7 | 11.5 | — |
| Ratio Rápido | 3.3 | 11.2 | — |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Flujo de caja libre | $-52M | $-24M | — |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.